Mersana Therapeutics, Inc. (MRSN)
28.54
+0.20
(+0.69%)
USD |
NASDAQ |
Dec 15, 16:00
28.54
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Research and Development Expense (Annual): 73.02M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cidara Therapeutics, Inc. | 71.88M |
| Day One Biopharmaceuticals, Inc. | 227.70M |
| Cue Biopharma, Inc. | 35.93M |
| Scholar Rock Holding Corp. | 182.61M |
| ETHZilla Corp. | 1.969M |